We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Uterine Artery Embolization for Fibroid Treatment

By HospiMedica staff writers
Posted on 29 Jan 2001
A new minimally invasive treatment for symptomatic uterine fibroids uses uterine artery embolization (UAE) to block blood flow to the vessels feeding a fibroid, thereby reducing the associated symptoms. More...
The treatment is now in a multicenter clinical trial.

The standard surgical therapy for fibroids has been hysterectomy and myomectomy. Successful completion of the clinical trial may demonstrate that UAE offers women an effective alternative to surgery for fibroid treatment. The trial is designed to evaluate the safety and efficacy of the FasTracker 325 infusion catheter and Contour-PVA embolic particles used to perform UAE, which are the products of Boston Scientific (Natick, MA, USA).

"This effort is a landmark research project that should definitively demonstrate the value of this therapy as a preferred treatment option,” noted John C. Lipman, M.D., Piedmont Hospital (Atlanta, GA, USA), who treated the trial's first patient.



Related Links:
Boston Scientific

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.